PDF(Pubmed)
Abstract：
BACKGROUND: Premenstrual dysphoric disorder (PMDD) is a debilitating condition, affecting women of reproductive age. It is characterized by severe periodic physical and psychological symptoms, which end after the onset of menstruation. This study aimed to evaluate the effectiveness of emotion-focused therapy (EFT) for PMDD patients.
METHODS: A total of 48 PMDD women, in the age range of 18-44 years, were randomly assigned to two intervention and control groups. The intervention group participated in 16 weeks of EFT treatment, while the control group was selected based on the waiting list (waitlist control group) and followed-up after three months. Forty-four patients finally completed this study. The participants completed the Premenstrual Syndrome Screening Tool (PSST), Difficulties in Emotion Regulation Scale (DERS), and Depression Anxiety Stress Scale-21 (DASS-21) in the first premenstrual period before treatment, the first premenstrual period after treatment, and the premenstrual period three months after treatment.
RESULTS: Based on the repeated measure analysis of variances, the total score of DERS and the total score of PSST decreased significantly (P < 0.05). Also, in DASS-21, the scores of depression and stress subscales reduced significantly (P < 0.05), while there was no significant decrease in the score of anxiety subscale (P > 0.05).
CONCLUSIONS: Based on the present results, EFT can be an effective treatment for alleviating the symptoms of PMDD. This treatment can reduce the emotion regulation difficulties of women with PMDD and alleviate the symptoms of depression and stress.
BACKGROUND: Iranian Registry of Clinical Trials, IRCT ID: IRCT20220920055998N1, Registered on: 12/2/2023.
METHODS: A total of 48 PMDD women, in the age range of 18-44 years, were randomly assigned to two intervention and control groups. The intervention group participated in 16 weeks of EFT treatment, while the control group was selected based on the waiting list (waitlist control group) and followed-up after three months. Forty-four patients finally completed this study. The participants completed the Premenstrual Syndrome Screening Tool (PSST), Difficulties in Emotion Regulation Scale (DERS), and Depression Anxiety Stress Scale-21 (DASS-21) in the first premenstrual period before treatment, the first premenstrual period after treatment, and the premenstrual period three months after treatment.
RESULTS: Based on the repeated measure analysis of variances, the total score of DERS and the total score of PSST decreased significantly (P < 0.05). Also, in DASS-21, the scores of depression and stress subscales reduced significantly (P < 0.05), while there was no significant decrease in the score of anxiety subscale (P > 0.05).
CONCLUSIONS: Based on the present results, EFT can be an effective treatment for alleviating the symptoms of PMDD. This treatment can reduce the emotion regulation difficulties of women with PMDD and alleviate the symptoms of depression and stress.
BACKGROUND: Iranian Registry of Clinical Trials, IRCT ID: IRCT20220920055998N1, Registered on: 12/2/2023.
摘要：
背景：经前烦躁不安症（PMDD）是一种使人衰弱的疾病，影响育龄妇女。它的特点是严重的周期性生理和心理症状，月经开始后结束。本研究旨在评估情绪聚焦疗法（EFT）对PMDD患者的有效性。
方法：共有48名PMDD女性，年龄在18-44岁之间,随机分为干预组和对照组。干预组参加16周的EFT治疗,而对照组则根据等待名单选择（等待名单对照组），并在三个月后进行随访。44名患者最终完成了这项研究。参与者完成了经前综合症筛查工具（PSST），情绪调节量表(DERS)的难点，治疗前第一个经前期抑郁焦虑应激量表-21(DASS-21),治疗后的第一个经前期，经前期治疗后三个月。
结果：基于方差的重复测量分析，DERS总分和PSST总分显著降低(P<0.05)。此外，在DASS-21中，抑郁和压力分量表得分显着降低（P<0.05），焦虑量表评分无明显下降(P>0.05)。
结论：根据目前的结果，EFT可以有效缓解PMDD的症状。这种治疗方法可以减轻PMDD女性的情绪调节困难，减轻抑郁和压力症状。
背景：伊朗临床试验注册，IRCTID：IRCT20220920055998N1，注册时间：12/2/2023。
方法：共有48名PMDD女性，年龄在18-44岁之间,随机分为干预组和对照组。干预组参加16周的EFT治疗,而对照组则根据等待名单选择（等待名单对照组），并在三个月后进行随访。44名患者最终完成了这项研究。参与者完成了经前综合症筛查工具（PSST），情绪调节量表(DERS)的难点，治疗前第一个经前期抑郁焦虑应激量表-21(DASS-21),治疗后的第一个经前期，经前期治疗后三个月。
结果：基于方差的重复测量分析，DERS总分和PSST总分显著降低(P<0.05)。此外，在DASS-21中，抑郁和压力分量表得分显着降低（P<0.05），焦虑量表评分无明显下降(P>0.05)。
结论：根据目前的结果，EFT可以有效缓解PMDD的症状。这种治疗方法可以减轻PMDD女性的情绪调节困难，减轻抑郁和压力症状。
背景：伊朗临床试验注册，IRCTID：IRCT20220920055998N1，注册时间：12/2/2023。
